236 related articles for article (PubMed ID: 23457158)
1. Personalised medicine for cystic fibrosis: treating the basic defect.
Elborn JS
Eur Respir Rev; 2013 Mar; 22(127):3-5. PubMed ID: 23457158
[No Abstract] [Full Text] [Related]
2. Precision Genomic Medicine in Cystic Fibrosis.
Chang EH; Zabner J
Clin Transl Sci; 2015 Oct; 8(5):606-10. PubMed ID: 26073768
[TBL] [Abstract][Full Text] [Related]
3. Targeting a genetic defect: cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis.
Derichs N
Eur Respir Rev; 2013 Mar; 22(127):58-65. PubMed ID: 23457166
[TBL] [Abstract][Full Text] [Related]
4. The impact of personalised therapies on respiratory medicine.
Elborn JS
Eur Respir Rev; 2013 Mar; 22(127):72-4. PubMed ID: 23457168
[TBL] [Abstract][Full Text] [Related]
5. Making precision medicine personal for cystic fibrosis.
Manfredi C; Tindall JM; Hong JS; Sorscher EJ
Science; 2019 Jul; 365(6450):220-221. PubMed ID: 31320522
[No Abstract] [Full Text] [Related]
6. Ivacaftor treatment in patients with cystic fibrosis and the G551D-CFTR mutation.
Sermet-Gaudelus I
Eur Respir Rev; 2013 Mar; 22(127):66-71. PubMed ID: 23457167
[TBL] [Abstract][Full Text] [Related]
7. Lumacaftor and ivacaftor in the management of patients with cystic fibrosis: current evidence and future prospects.
Kuk K; Taylor-Cousar JL
Ther Adv Respir Dis; 2015 Dec; 9(6):313-26. PubMed ID: 26416827
[TBL] [Abstract][Full Text] [Related]
8. [Cystic fibrosis: From gene discovery to precision medicine].
Férec C
Med Sci (Paris); 2021; 37(6-7):618-624. PubMed ID: 34180821
[TBL] [Abstract][Full Text] [Related]
9. A new era of personalized medicine for cystic fibrosis - at last!
Quon BS; Wilcox PG
Can Respir J; 2015; 22(5):257-60. PubMed ID: 26083544
[TBL] [Abstract][Full Text] [Related]
10. An innovative strategy for personalised medicine in a CFSPID case that evolved with time.
Twynam-Perkins J; Fall A; Lefferts JW; Urquhart DS
Paediatr Respir Rev; 2023 Sep; 47():23-26. PubMed ID: 37407313
[TBL] [Abstract][Full Text] [Related]
11. [Challenges of personalized medicine for cystic fibrosis].
Corvol H; Taytard J; Tabary O; Le Rouzic P; Guillot L; Clement A
Arch Pediatr; 2015 Jul; 22(7):778-86. PubMed ID: 26021452
[TBL] [Abstract][Full Text] [Related]
12. [Cystic fibrosis and gene therapy].
Setoguchi Y; Yokoyama T
Nihon Rinsho; 2005 Dec; 63 Suppl 12():607-16. PubMed ID: 16416861
[No Abstract] [Full Text] [Related]
13. Personalised medicine for non-classic cystic fibrosis resulting from rare CFTR mutations.
McCravy MS; Quinney NL; Cholon DM; Boyles SE; Jensen TJ; Aleksandrov AA; Donaldson SH; Noone PG; Gentzsch M
Eur Respir J; 2020 Jul; 56(1):. PubMed ID: 32265312
[No Abstract] [Full Text] [Related]
14. Towards personalized medicine for cystic fibrosis patients with rare mutations.
Csanády L
J Physiol; 2024 Jan; 602(2):257-258. PubMed ID: 38167788
[No Abstract] [Full Text] [Related]
15. Personalised CFTR pharmacotherapeutic response testing and therapy of cystic fibrosis.
McCarthy C; Brewington JJ; Harkness B; Clancy JP; Trapnell BC
Eur Respir J; 2018 Jun; 51(6):. PubMed ID: 29563174
[No Abstract] [Full Text] [Related]
16. Current progress in cystic fibrosis: is this a disease elusive to therapy?
Brown C
Pulm Pharmacol Ther; 2008 Aug; 21(4):585-7. PubMed ID: 18313958
[No Abstract] [Full Text] [Related]
17. [Evidence-based treatment of cystic fibrosis].
Ringshausen FC; Hellmuth T; Dittrich AM
Internist (Berl); 2020 Dec; 61(12):1212-1229. PubMed ID: 33201261
[TBL] [Abstract][Full Text] [Related]
18. [Modifier genes and cystic fibrosis].
Corvol H; Flamant C; Vallet C; Clement A; Brouard J
Arch Pediatr; 2006 Jan; 13(1):57-63. PubMed ID: 16274977
[TBL] [Abstract][Full Text] [Related]
19. Novel de novo large deletion in cystic fibrosis transmembrane conductance regulator gene results in a severe cystic fibrosis phenotype.
Norek A; Stremska M; Sobczyńska-Tomaszewska A; Wertheim-Tysarowska K; Dmeńska H; Jurek M
J Pediatr; 2011 Aug; 159(2):343-6.e1. PubMed ID: 21663921
[TBL] [Abstract][Full Text] [Related]
20. A personalized medicine approach to optimize care for a pediatric cystic fibrosis patient with atypical clinical symptoms.
Lee J; Husami A; Arora K; Zhang W; Kadri F; Yarlagadda S; Moon C; Mun KS; Zhang K; Huang Y; Liyanage P; Brewington J; Clancy JP; Shaikhkhalil A; Paul G; Naren AP
Pediatr Pulmonol; 2024 Jan; 59(1):229-232. PubMed ID: 37818777
[No Abstract] [Full Text] [Related]
[Next] [New Search]
